3M Drug Delivery Systems Announces Licensing Agreement with Spirig Pharma

3M MMM Drug Delivery Systems has signed an exclusive licensing agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products. Spirig Pharma AG will utilize one of 3M's immune response modifier (IRM) molecules to further its development of treatment for sun damaged skin.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContractsDiversified Commercial & Professional ServicesIndustrial ConglomeratesIndustrials
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!